🔗 Permalink

Inventor profile of:

David A. Moreno

City:

Boulder, Colorado

Country:

United States

Published Applications:

31

Last publication date:

2024-02-29

Top Assignees for applications by David A. Moreno

The entities that hold a legal rights for patent applications filed by inventor Moreno David A.:

ARRAY BIOPHARMA INC. 25 Boulder, CO United States
Genentech, Inc. 8 South San Francisco, CA United States
Array BioPharma Inc. 2 Indianapolis, IN United States
Loxo Oncology Inc. 2 Indianapolis, IN United States
Loxo Oncology, Inc. 1 Stamford, CT United States
ELI LILLY AND COMPANY 1 Indianapolis, IN United States
Array BioPharma Inc. 1 Boudler, CO United States
Array BioPharma Inc. 1 Boulder, United States

Recent patent applications by Moreno David A.

David A. Moreno from Boulder, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-02-29

US20240066029A1

Human necessities

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

#2 | 2023-03-23

US20230090520A1

Human necessities

SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS

#3 | 2022-10-06

US20220313676A1

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#4 | 2022-04-21

US20220119396A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors

#5 | 2022-03-17

US20220081438A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases

#6 | 2021-12-09

US20210380609A1

Chemistry; metallurgy

Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

#7 | 2021-06-24

US20210186959A1

Human necessities

SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS

#8 | 2020-12-24

US20200399279A1

Chemistry; metallurgy

Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors

#9 | 2020-12-10

US20200383966A9

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#10 | 2020-10-29

US20200339589A1

Chemistry; metallurgy

Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors

#11 | 2020-10-29

US20200339579A1

Chemistry; metallurgy

Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors

#12 | 2020-10-01

US20200308194A1

Chemistry; metallurgy

Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile

#13 | 2020-02-20

US20200055860A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors

#14 | 2020-01-30

US20200030311A1

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#15 | 2019-06-20

US20190183886A1

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#16 | 2019-04-11

US20190106438A1

Chemistry; metallurgy

Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

#17 | 2018-05-31

US20180148445A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#18 | 2018-05-17

US20180134703A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#19 | 2018-05-17

US20180134702A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#20 | 2018-05-17

US20180133213A1

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#21 | 2018-05-17

US20180133207A1

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#22 | 2018-05-17

US20180133200A1

Human necessities

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

#23 | 2018-05-10

US20180127393A1

Chemistry; metallurgy

Serine/threonine kinase inhibitors

#24 | 2017-12-07

US20170348310A1

Human necessities

Serine/threonine kinase inhibitors

#25 | 2016-10-20

US20160304519A1

Chemistry; metallurgy

Serine/threonine kinase inhibitors

#26 | 2016-10-20

US20160303126A1

Human necessities

Serine/threonine kinase inhibitors

#27 | 2016-05-05

US20160122316A1

Chemistry; metallurgy

Serine/threonine kinase inhibitors

#28 | 2015-03-26

US20150087664A1

Chemistry; metallurgy

Substituted quinazolines as serine/threonine kinase inhibitors

#29 | 2014-09-04

US20140249127A1

Chemistry; metallurgy

Serine/threonine kinase inhibitors

#30 | 2014-08-14

US20140228349A1

Chemistry; metallurgy

5,7-SUBSTITUTED-IMIDAZO[1,2-C]PYRIMIDINES

#31 | 2013-09-26

US20130252934A1

Human necessities

Serine/threonine kinase inhibitors

InventorID:

457161 ⎘